Join

Store

Chapters

APIC Action Center

Our Action Center makes it easy to action send a relevant letter to your legislators in seconds.

Take Action Now
Menu
Back to Policy Updates

FDA/ASPR Extend Shelf-Life for Bebtelovimab

FDA/ASPR Extend Shelf-Life for Bebtelovimab

5/25/22 — The FDA and HHS/ASPR announced the authorization of an extension to the shelf-life from 12 months to 18 months for specific lots of the refrigerated Eli Lilly monoclonal antibody, bebtelovimab, which is currently authorized for emergency use.